Duck Enteritis Virus/Anatid Herpesvirus 1 antibody and antigen (recombinant protein)

 Download 

Diagnostic anti-Duck Enteritis Virus/Anatid Herpesvirus 1 antibodies pairs and antigen for animal health (animal Avian/Bird/Poultry infectious disease Duck plague) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Go to Avian/Bird/Poultry disease testing products collection >>

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-VT-P204-Ag01	Recombinant Duck Enteritis Virus/Anatid Herpesvirus 1 protein	$3090.00
GMP-VT-P204-Ab01	Anti-Duck Enteritis Virus/Anatid Herpesvirus 1 mouse monoclonal antibody (mAb)	$3090.00
GMP-VT-P204-Ab02	Anti-Duck Enteritis Virus/Anatid Herpesvirus 1 mouse monoclonal antibody (mAb)	$3090.00

Size： 1mg | 10mg | 100mg

Product Description

Cat No.	GMP-VT-P204-Ag01
Product Name	Recombinant Duck Enteritis Virus/Anatid Herpesvirus 1 protein
Pathogen	Duck Enteritis Virus/Anatid Herpesvirus 1
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Duck Enteritis Virus/Anatid Herpesvirus 1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Duck Enteritis Virus/Anatid Herpesvirus 1 level test of animal Avian/Bird/Poultry infectious disease with Duck plague.
Tag	His
Product description	Recombinant Duck Enteritis Virus/Anatid Herpesvirus 1 proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No.	GMP-VT-P204-Ab01,GMP-VT-P204-Ab02
Pathogen	Duck Enteritis Virus/Anatid Herpesvirus 1
Product Name	Anti-Duck Enteritis Virus/Anatid Herpesvirus 1 mouse monoclonal antibody (mAb)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Duck Enteritis Virus/Anatid Herpesvirus 1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Duck Enteritis Virus/Anatid Herpesvirus 1 antibodies in Duck Enteritis Virus/Anatid Herpesvirus 1 level test of animal Avian/Bird/Poultry infectious disease with Duck plague.
Product description	Anti-Duck Enteritis Virus/Anatid Herpesvirus 1 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Duck Enteritis Virus/Anatid Herpesvirus 1 antibodies./td>
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Pathogen

Duck Enteritis Virus (DEV), also known as Anatid Herpesvirus 1 (AHV-1), is a highly infectious pathogen that infects ducks and geese, causing duck viral enteritis (DVE). The virus belongs to the family Herpesviridae, which includes other important animal and human pathogens such as herpes simplex viruses, varicella-zoster virus, and cytomegalovirus.

DEV or AHV-1 is classified as a double-stranded DNA virus that has a genome of 162 kb, enclosed within an icosahedral capsid, further surrounded by an envelope containing viral glycoproteins. Glycoprotein B (gB) and thymidine kinase (TK) are essential genes and proteins involved in DEV or AHV-1 replication, and they serve as targets in sensitive diagnostic assays such as polymerase chain reaction (PCR) and quantitative PCR (qPCR).

DEV or AHV-1 is primarily transmitted through direct contact with infected birds or through contaminated feed, water, and equipment. The incubation period typically ranges from 2-5 days, after which infected birds show clinical signs and symptoms. DVE primarily affects the gastrointestinal and nervous systems of infected birds, leading to diarrhea, vomiting, depression, tremors, paralysis, and high mortality rates in susceptible populations.

Diagnosis of DVE mainly relies on the detection of DEV or AHV-1 genetic material or antibodies using molecular diagnostic techniques and serological assays. Nucleic acid-based tests such as PCR and qPCR are highly specific and sensitive diagnostic methods that detect specific genes such as gB and TK in virus-infected samples. On the other hand, serological testing may detect antibodies against DEV or AHV-1 glycoproteins in the serum of infected birds.

Several prevention and control measures are currently available to minimize the spread of DEV or AHV-1 among duck populations. Vaccines are considered the most effective measure, and several commercial vaccines are available for use in duck flocks. Vaccination is typically administered during the rearing period, and booster doses are routinely given every 6-12 months to ensure long-lasting immunity. It is also essential to maintain high levels of biosecurity in duck farms to prevent the introduction of the virus into susceptible populations. This can be achieved through proper disinfection of equipment and facilities, limiting access to the farm, and avoiding contact with infected ducks.

In conclusion, DEV or AHV-1 is a highly infectious pathogen that causes significant economic losses in duck populations worldwide. Rapid detection and early intervention using sensitive diagnostic methods are critical in controlling the spread of the disease. Vaccination and strict biosecurity measures remain the most effective strategies to minimize the impact of DVE in duck flocks.

About GDU